Page last updated: 2024-09-04

technetium tc 99m (sn)methylenediphosphonate and Osteoporosis

technetium tc 99m (sn)methylenediphosphonate has been researched along with Osteoporosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Caniggia, A; Vattimo, A1
Duursma, SA; Hoekstra, A; Raymakers, JA; Savelkoul, TJ; van Rijk, PP; Visser, WJ1

Other Studies

2 other study(ies) available for technetium tc 99m (sn)methylenediphosphonate and Osteoporosis

ArticleYear
Kinetics of 99mtechnetium-tin-methylene-diphosphonate in normal subjects and pathological conditions: a simple index of bone metabolism.
    Calcified tissue international, 1980, Volume: 30, Issue:1

    Topics: Adolescent; Adult; Aged; Bone and Bones; Bone Diseases; Bone Neoplasms; Diphosphonates; Humans; Hyperparathyroidism; Kidney Failure, Chronic; Kinetics; Liver Cirrhosis; Middle Aged; Osteitis Deformans; Osteomalacia; Osteoporosis; Technetium; Technetium Tc 99m Medronate

1980
The value of local 99mTc(Sn)-MDP bone to soft tissue uptake ratio in osteoporosis, before and during fluoride therapy.
    European journal of nuclear medicine, 1990, Volume: 16, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Connective Tissue; Female; Humans; Male; Middle Aged; Osteoporosis; Radionuclide Imaging; Sodium Fluoride; Tablets, Enteric-Coated; Technetium Tc 99m Medronate

1990